Órgano oficial de Instituto Panvascular de Occidente, S.C.
Aspergilosis Asociada a COVID19 en UCI
PDF Editorial Letter (English)

Palabras clave

COVID-19
Aspergillosis pulmonar
Unidad de Cuidados Intensivos

Categorías

Cómo citar

1.
Cascais Costa C, André S. Aspergilosis Asociada a COVID19 en UCI. Rev Med Clin [Internet]. 19 de abril de 2022 [citado 26 de junio de 2022];6(1):e19042206006. Disponible en: https://medicinaclinica.org/index.php/rmc/article/view/407

Resumen

Carta editorial presentada en el volumen 6 número 1 de Revista de medicina Clínica sobre Aspergillosis Pulmonar como  complicación de infección por SARS-COV-2

https://doi.org/10.5281/zenodo.6471439
PDF Editorial Letter (English)

Citas

Koehler P, Bassetti M, Chakrabarti A, Chen SCA, Colombo AL, Hoenigl M, Klimko N, Lass-Flörl C, Oladele RO, Vinh DC, Zhu LP, Böll B, Brüggemann R, Gangneux JP, Perfect JR, Patterson TF, Persigehl T, Meis JF, Ostrosky-Zeichner L, White PL, Verweij PE, Cornely OA; European Confederation of Medical Mycology; International Society for Human Animal Mycology; Asia Fungal Working Group; INFOCUS LATAM/ISHAM Working Group; ISHAM Pan Africa Mycology Working Group; European Society for Clinical Microbiology; Infectious Diseases Fungal Infection Study Group; ESCMID Study Group for Infections in Critically Ill Patients; Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy; Medical Mycology Society of Nigeria; Medical Mycology Society of China Medicine Education Association; Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology; Association of Medical Microbiology; Infectious Disease Canada. Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance. Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14. PMID: 33333012; PMCID: PMC7833078.

Montrucchio G, Lupia T, Lombardo D, Stroffolini G, Corcione S, De Rosa FG, Brazzi L. Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements. Ann Intensive Care. 2021 Sep 15;11(1):136. doi: 10.1186/s13613-021-00923-4. PMID: 34524562; PMCID: PMC8441237.

Koehler P, Cornely OA, Böttiger BW, Dusse F, Eichenauer DA, Fuchs F, Hallek M, Jung N, Klein F, Persigehl T, Rybniker J, Kochanek M, Böll B, Shimabukuro-Vornhagen A. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020 Jun;63(6):528-534. doi: 10.1111/myc.13096. Epub 2020 May 15. PMID: 32339350; PMCID: PMC7267243

Dimopoulos G, Almyroudi MP, Myrianthefs P, Rello J. COVID-19-Associated Pulmonary Aspergillosis (CAPA), Journal of Intensive Medicine, 2021 doi: 10.1016/j.jointm.2021.07.001. Epub 2021 7 Aug.

Borman AM, Palmer MD, Fraser M, Patterson Z, Mann C, Oliver D, Linton CJ, Gough M, Brown P, Dzietczyk A, Hedley M, McLachlan S, King J, Johnson EM. COVID-19-Associated Invasive Aspergillosis: Data from the UK National Mycology Reference Laboratory. J Clin Microbiol. 2020 Dec 17;59(1):e02136-20. doi: 10.1128/JCM.02136-20. PMID: 33087440; PMCID: PMC7771443.

Chong WH, Neu KP. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review. J Hosp Infect. 2021 Jul;113:115-129. doi: 10.1016/j.jhin.2021.04.012. Epub 2021 Apr 21. PMID: 33891985; PMCID: PMC8057923.

Meijer EFJ, Dofferhoff ASM, Hoiting O, Meis JF. COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series. Mycoses. 2021 Apr;64(4):457-464. doi: 10.1111/myc.13254. Epub 2021 Feb 16. PMID: 33569857; PMCID: PMC7986084.

Lai CC, Yu WL. COVID-19 associated with pulmonary aspergillosis: A literature review. J Microbiol Immunol Infect. 2021 Feb;54(1):46-53. doi: 10.1016/j.jmii.2020.09.004. Epub 2020 Sep 24. PMID: 33012653; PMCID: PMC7513876.

Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.

Derechos de autor 2022 Revista de Medicina Clínica